DIVISION OF MOLECULAR EPIDEMIOLOGY F. Kadlubar, Director L. Poirier, Acting Director MAJOR RESEARCH AREAS: Identification of genetic polymorphisms that.

Slides:



Advertisements
Similar presentations
Regulation of Consumer Tests in California AAAS Meeting June 1-2, 2009 Beatrice OKeefe Acting Chief, Laboratory Field Services California Department of.
Advertisements

Role of Vitamin D in Blood Malignancies Dr Imran Hilal.
MOLECULAR MECHANISMS INFLUENCING THE BIOMARKER LEVELS OF ENVIRONMENTAL GENOTOXIC EXPOSURE Bernadette Schoket Department of Molecular Environmental Epidemiology.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.
Chapter 11 Diet and Health
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.
Bios E-162b FALL 2010 Cancer review session Carlos O. Mendivil-Anaya, MD.
Computational Tools for Finding and Interpreting Genetic Variations Gabor T. Marth Department of Biology, Boston College
Environmental Health III. Epidemiology Shu-Chi Chang, Ph.D., P.E., P.A. Assistant Professor 1 and Division Chief 2 1 Department of Environmental Engineering.
Early programming hypothesis Wilfried Karmaus Reproductive Epidemiology EPI 824.
Epigenetics of Celiac Disease MEDICEL Malta 2011.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
PCR Application: Can Breast Cancer be Cured?. Normal, Healthy Cells Cells can change or differentiate to become specialised according to the tissue that.
 Most frequently diagnosed cancer worldwide › About 1.35 million new cases diagnosed worldwide each year  Leading cause of cancer deaths in the United.
 2 nd overall leading cause of cancer death in the United States › 3 rd in each sex  Approximately 6% of individuals in the US will develop a cancer.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Cruciferous Vegetables & Lung Cancer Sharon Lo, Courtney Wheeler, Taylor Seesholtz, & Stephanie Anderson.
PROSTATE CANCER AND SMOKING Kym Hickey MBBS, MPH Repatriation Medical Authority, Australia.
University of Utah Department of Human Genetics Pharmacogenomics Louisa A. Stark, Ph.D. Director.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 13 – BIOMARKERS Summary and final notes.
Smoking and sub-therapeutic fluvoxamine serum levels: Are epigenetics to blame? Kristen N. Gardner, Amanda N. King, Rachel E. Rarus, Janis M. Rood Department.
ILSI Risk Science Institute Acrylamide Toxicity: Research to Address Key Data Gaps Presented by Dr. Stephen S. Olin ILSI Risk Science Institute.
Vitamin D and breast cancer risk: epidemiological evidence Tom Rohan Dept. of Epidemiology and Population Health Albert Einstein College Of Medicine.
NOTES: CH 18 part 2 - The Molecular Biology of Cancer
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Epigenome 1. 2 Background: GWAS Genome-Wide Association Studies 3.
Molecular and Genetic Epidemiology Kathryn Penney, ScD January 5, 2012.
Understanding Cancer. What Is Cancer? Different Kinds of Cancer Lung Breast (women) Colon Bladder Prostate (men) Some common sarcomas: Fat Bone Muscle.
Epidemiology of Selected Cancers in Saudi Arabia
Computational research for medical discovery at Boston College Biology Gabor T. Marth Boston College Department of Biology
Chapter 8 Cancer. Chapter overview Introduction Carcinogenesis Physical activity and colorectal cancer Physical activity and breast cancer Physical activity.
CONTEXT SPECIFIC ROLE OF DEUBIQUITYLASE ENZYME, USP9X, IN HEAD AND NECK CANCER Devathri Nanayakkara Eskitis Institute for Drug Discovery Griffith University.
Cancer. What is Cancer? – –Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer, they.
Introduction of Department of Molecular Biology for Public Health in SCDC Ye Lu Shanghai Municipal Center for Disease Control & Prevention Shanghai Institute.
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
Epigenetics Heritable characteristics of the genome other than the DNA sequence Heritable during cell-division (mitosis) To a lesser extent also over generations.
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
Implications of the Current State of Scientific Knowledge David W K Acheson, M.D. Center for Food Safety and Applied Nutrition U.S. Food and Drug Administration.
Biobanks of Cerice Center for Gene Expression Research in Cancer Epidemiology Eiliv Lund, UiTø.
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
Effects of Smoking on Health Prepared by Amr Said Dahroug.
Pathogenesis Review Lecture Review September 15, 2014 Mariel Arvizu, MD Doctoral Student Harvard School Public Health.
Dietary fish oil modulates the effect of dimethylhydrazine-induced colon cancer in rats By G.E. Rasmy, W.K.B. Khalil, S.A. Moharib, A.A. Kawkab, and E.W.
Fibrinogen in South Asians Dr Kirti Kain MD MRCP Academic Unit of Molecular Vascular Medicine Leeds University Leeds United Kingdom.
Introduction Hereditary predisposition (mutations in BRCA1 and BRCA2 genes) contribute to familial breast cancers. Eighty percent of the.
Paolo Vineis University of Torino and ISI Foundation, Torino, Italy address: GENE-ENVIRONMENT INTERACTIONS IN CANCER.
The Inflammatory Breast Cancer Cancer Registry Paul H. Levine, M.D. Paul H. Levine, M.D. The George Washington University School of Public Health and Health.
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Toxic effects Acute / chronic Reversible / irreversible Immediate / delayed Idiosyncratic - hypersensitivity Local / systemic Target organs.
GENETIC MARKERS OF CORONARY ARTERY DISEASE RISK GALYA ATANASOVA MD, PhD DOMINIC JAMES.
Toxicogenomics Dr. M. Zdanowicz.
Human Genetics: concepts and applications 6th edition Ricki Lewis Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
Breast cancer Not a single disease. Type and stage. Grade/Lympho-vascular invasion Molecular biology. ER\PR Her-2-neu Other. Gene expression profiling.
Different microarray applications Rita Holdhus Introduction to microarrays September 2010 microarray.no Aim of lecture: To get some basic knowledge about.
The Importance of Epigenetic Phenomena in Regulating Activity of the Genetic Material Sin Chan.
Health Benefits PHTYOME FP7-SME PHYTOME (315683) Brussels, November 16, 2015 Prof. dr. Theo M. de Kok Coordinator PHYTOME project Maastricht University,
GENETIC BIOMARKERS.
Cancer.
EPIDEMIOLOGY.
Uncontrolled Cell Division and Differentiation
Cancer Epidemiology Kara P. Wiseman, MPH, Phd
Case Study #2 Session 1, Day 3, Liu
Genetics and epigenetics of NAFLD and NASH
Presentation transcript:

DIVISION OF MOLECULAR EPIDEMIOLOGY F. Kadlubar, Director L. Poirier, Acting Director MAJOR RESEARCH AREAS: Identification of genetic polymorphisms that influence carcinogen metabolism, DNA repair and individual cancer susceptibility. Chemoprevention

Division of Molecular Epidemiology CURRENT STAFF The Division consists of:  7 senior staff (6.5 FTEs, including 1 vacant)  8 postdoctoral appointees  12 support staff (6 FTEs)  2 graduate students  2 administrative staff Collaboration with UAMS/VA involve shared laboratory resources with Dr. Lang that consist of:  1 postdoctoral fellow  8 support staff  1 graduate student

Principal Investigator: Fred Kadlubar Current Projects : Genetic Polymorphisms, DNA Adduct Detection in Humans, and Molecular Epidemiologic Studies Applications of DNA Microarray Chip to Population-based Studies

STUDY DESIGN African-American (n=54), Hispanic (n=72), and Caucasian (n=66) girls, 9.5  0.3 years of age were entered into the study. Dietary intake, weight, BMI, environmental exposures and personal information were obtained. Onset of puberty was determined from Tanner breast scores, with T2B designated as initial breast growth. Blood samples were taken and genotypes for CYP17, CYP1A2, CYP1B1, and CYP3A4 were determined.

Genotype Distribution at Onset of Puberty T2B No. of Individuals 0 CYP17*A1/*A1CYP17*A1/*A2CYP17*A2/*A2 Genotype

B. Coles Glutathione S-transferase (GST) polymorphism: Susceptibility to cancer and response to chemotherapeutics Major studies: Case-control study of colorectal cancer incidence with respect to hGSTA1 polymorphism (F. Kadlubar).Case-control study of colorectal cancer incidence with respect to hGSTA1 polymorphism (F. Kadlubar). Retrospective case study on survival of breast cancer after chemotherapy with respect to GST genotype and GST phenotype in tumor (C. Ambrosone, C. Sweeney, F. Kadlubar).Retrospective case study on survival of breast cancer after chemotherapy with respect to GST genotype and GST phenotype in tumor (C. Ambrosone, C. Sweeney, F. Kadlubar). Recurrence of colorectal polyps with respect to GST genetic polymorphism, MTHFR & GPX polymorphism (F. Kadlubar).Recurrence of colorectal polyps with respect to GST genetic polymorphism, MTHFR & GPX polymorphism (F. Kadlubar).

GSTA1  g/mg cytosolic protein GSTA2  g/mg cytosolic protein Expression of GSTA1/GSTA2 in human liver A1*A A1*B A1*A/*B GSTA1  g/mg cytosolic protein GSTA2  g/mg cytosolic protein

GSTA1  g/mg cytosolic protein GSTA2  g/mg cytosolic protein Expression of GSTA1/GSTA2 in human liver according to hGSTA1 genotype A1*A A1*B A1*A/*B

Proportion Surviving Years from Diagnosis *A/*A *A/*B *B/*B Overall Survival among 196 Women with Breast Cancer by GSTA1 Genotype

B. Coles FUTURE DIRECTIONS Critical examination of study breast cancer response to chemotherapy: additional study populations; pharmacogenetic variations; alterated enzyme kinetics. Examination of additional polymorphism in GSTs (protein & gene) and of tissue-specific GST expression as potential factors in susceptibility to disease and chemotherapeutic response. Continuation of study: GSTs and colorectal neoplasia (Arizona Cancer Center).

Validation of DNA SNP microarray chip for application to population-based studies. Investigation of genetic and epigenetic alterations of specific cells using laser capture microdissection-based approach. Examination of mutations in mitochonrdrial DNA to investigate prospective role of oxidative stress in prostate cancer. Determination of hypermethylation of GSTP1 promoter as an early marker of prostatic cancer. Junjian Chen Somatic Alteration of Prostate Cancer and Precursor Lesions

George Hammons Mechanisms of CYP1A2 gene regulationPROJECTS: Hepatic DNA methyltransferase activity in smokers (B. Lyn-Cook et al.). Hepatic DNA methyltransferase activity in smokers (B. Lyn-Cook et al.). Determination of individual methylation profiles, gene expression, and enzyme activity of CYP1A2 in human livers (B. Lyn-Cook, Y. Yan-Sanders). Determination of individual methylation profiles, gene expression, and enzyme activity of CYP1A2 in human livers (B. Lyn-Cook, Y. Yan-Sanders).ACCOMPLISHMENTS: Hepatic DNA methyltransferase was significantly higher in smokers than in non-smokers. Hepatic DNA methyltransferase was significantly higher in smokers than in non-smokers. Hypermethylation of the promoter region of the CYP1A2 gene was associated with decreased expression. Hypermethylation of the promoter region of the CYP1A2 gene was associated with decreased expression.

LIVER CYP1A2 EXPRESSION IN SMOKERS VS. PROMOTER METHYLATION STATUS

B. Lyn-Cook B. Lyn-Cook IN VITRO STUDIES ON PANCREATIC CANCER AND TOXICITY Major Projects: Biomarkers of pancreatic cancer. Establish biomarkers of cancer in high risk groups, e.g. smokers vs. nonsmokers. Develop in vitro predictive bioassays for chemopreventive agents. Toxicity. Investigate the molecular and cellular effects of nicotine, soy, and tea components on pancreatic cells in culture. Determine the mechanism of action of such agents.

B. Lyn-Cook Future Plans Undertake mechanistic studies on the biological and pharmacological actions of chemopreventive agents. Undertake mechanistic studies on the biological and pharmacological actions of chemopreventive agents. Conduct site-specific methylation studies on the promoter region of the IGF-1 gene in lymphocytes from a case-control study of colon adenomas. Conduct site-specific methylation studies on the promoter region of the IGF-1 gene in lymphocytes from a case-control study of colon adenomas. Conduct global methylation studies on H-K-ras methylation patterns in human lymphocytes from a case-control study of colon adenomas. Conduct global methylation studies on H-K-ras methylation patterns in human lymphocytes from a case-control study of colon adenomas.

L. Poirier Major Projects : DNA methylation and cancer risk in humans and experimental animals. Abnormal methyl metabolism in nonneoplastic diseases.

PLASMA HOMOCYSTEINE IN RATS FED A METHYL-DEFICIENT, HOMOCYSTINE-SUPPLEMENTED DIET

INTIMAL HYPERPLASIA AS A FUNCTION OF PLASMA HOMOCYSTEINE LEVELS

CORRELATIONS BETWEEN HOMOCYST(E)INE AND GROWTH- AND SAM-RELATED PARAMETERS L. Poirier RECENT CORRELATIONS BETWEEN HOMOCYST(E)INE AND GROWTH- AND SAM-RELATED PARAMETERS Dietary homocystine raises the plasma level of homocysteine in rats and accelerates the formation of atherosclerotic plaques. In diabetics, high plasma levels of homocysteine is accompanied by elevated blood levels of both S- adenosylmethionine (SAM) and S-adenosylhomocysteine. In both humans and rats, SAM availability appears to be inversely proportional to calorie intake.

FUTURE PROJECTS L. Poirier FUTURE PROJECTS Collaborate with NCI on methylation parameters in a case/control colon adenoma study. Collaborate with NCI on methylation parameters in a case/control colon adenoma study. Extend collaborative studies on DNA and gene methylation in rats undergoing hepatocarcinogenesis by dietary methyl deprivation. Extend collaborative studies on DNA and gene methylation in rats undergoing hepatocarcinogenesis by dietary methyl deprivation. Complete collaborative clinical studies on abnormal methyl metabolism associated with nonneoplastic disease. Complete collaborative clinical studies on abnormal methyl metabolism associated with nonneoplastic disease. Coorganize trans-HHS Workshop: Diet, DNA Methylation Processes and Health. Coorganize trans-HHS Workshop: Diet, DNA Methylation Processes and Health.